| |
| |
|
| Insider
Information: |
Dickinson Andrew D |
| Relationship: |
Chief Financial Officer |
| City: |
Westminster |
| State: |
CO |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
134,983 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$9,045,211 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
134,983 |
|
|
| Total
Value |
$9,045,211 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
Chief Financial Officer |
2024-03-10 |
134,983 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
64 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial OfficerOf |
• – – |
2019-11-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,927 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• • – |
2019-11-10 |
4 |
D |
$65.38 |
$34,063 |
D/D |
(521) |
5,539 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• • – |
2019-11-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,133 |
6,060 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• • – |
2020-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
3,834 |
9,373 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• • – |
2020-02-06 |
4 |
D |
$68.21 |
$40,858 |
D/D |
(599) |
10,592 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• • – |
2020-02-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,818 |
11,191 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• • – |
2020-02-15 |
4 |
A |
$53.67 |
$21,199 |
D/D |
395 |
10,987 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• • – |
2020-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
769 |
11,756 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• • – |
2020-03-10 |
4 |
D |
$72.34 |
$25,753 |
D/D |
(356) |
11,400 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• • – |
2020-06-10 |
4 |
D |
$77.07 |
$130,325 |
D/D |
(1,691) |
13,355 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• • – |
2020-06-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,646 |
15,046 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• • – |
2020-08-10 |
4 |
D |
$68.51 |
$70,017 |
D/D |
(1,022) |
14,639 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• • – |
2020-08-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,306 |
15,661 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• • – |
2020-11-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,046 |
17,685 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• • – |
2020-11-10 |
4 |
D |
$60.62 |
$84,807 |
D/D |
(1,399) |
16,286 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• • – |
2021-01-26 |
4 |
D |
$66.70 |
$58,563 |
D/D |
(878) |
31,263 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• • – |
2021-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
15,855 |
32,141 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• • – |
2021-02-06 |
4 |
D |
$68.46 |
$36,831 |
D/D |
(538) |
32,543 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• • – |
2021-02-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,818 |
33,081 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Financial Officer |
• • – |
2021-02-15 |
4 |
A |
$56.86 |
$20,696 |
D/D |
364 |
32,907 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Financial Officer |
• • – |
2021-03-10 |
4 |
D |
$63.91 |
$113,185 |
D/D |
(1,771) |
34,930 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Financial Officer |
• • – |
2021-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,794 |
36,701 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Financial Officer |
• • – |
2021-06-10 |
4 |
D |
$69.29 |
$111,210 |
D/D |
(1,605) |
36,971 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Financial Officer |
• • – |
2021-06-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,646 |
38,576 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Financial Officer |
• • – |
2021-08-15 |
4 |
A |
$55.08 |
$55 |
D/D |
1 |
36,972 |
0 |
- |
|
64 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
